# Moderna

> American biotechnology company

**Wikidata**: [Q17081612](https://www.wikidata.org/wiki/Q17081612)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Moderna)  
**Source**: https://4ort.xyz/entity/moderna

## Summary
Moderna is an American biotechnology company specializing in the development and production of mRNA-based vaccines and therapies. Founded in 2010, it is headquartered in Cambridge, Massachusetts, and is publicly traded on the Nasdaq stock exchange. The company is renowned for its breakthrough mRNA-1273 vaccine, which became the first mRNA vaccine approved for COVID-19 in 2020.

## Key Facts
- Founded in 2010 by Noubar Afeyan, Robert S. Langer, and Stéphane Bancel.
- Headquartered in Cambridge, Massachusetts, United States.
- Publicly traded on the Nasdaq stock exchange under the ticker symbol MRNA.
- Specializes in biotechnology, particularly mRNA vaccines and therapies.
- Developed the mRNA-1273 vaccine, the first mRNA-based COVID-19 vaccine approved by the FDA in 2020.
- Owned by key figures including Noubar Afeyan, Stéphane Bancel, and Robert S. Langer.
- Affiliated with researchers such as Moncef Slaoui and Derrick Rossi.
- Has a revenue history including $60.2 million in 2010, $135.07 million in 2011, and $205.83 million in 2012.
- Reported net profits and losses from 2010 to 2019, with a notable $12.2 billion net profit in 2019.
- Employed 680 employees in 2010, growing to 5,800 by 2019.
- Operates under the field of work in biotechnology and pharmaceutical industries.
- Has a Wikipedia presence with 46 sitelinks, indicating global recognition.
- Uses multiple identifiers, including ISIN US60770K1079 and LEI 549300EI6OKH5K5Q2G38.
- Website: [modernatx.com](https://www.modernatx.com/).

## FAQs
**What is Moderna known for?**
Moderna is known for developing the mRNA-1273 vaccine, the first mRNA-based COVID-19 vaccine approved by the FDA in 2020. It is a pioneer in biotechnology, particularly in mRNA vaccines and therapies.

**Who founded Moderna?**
Moderna was founded in 2010 by Noubar Afeyan, Robert S. Langer, and Stéphane Bancel. Afeyan is an American entrepreneur, Langer is a biomedical engineer, and Bancel is the current CEO.

**Where is Moderna headquartered?**
Moderna is headquartered in Cambridge, Massachusetts, United States. The city is known for its strong biotechnology and academic institutions.

**What industries is Moderna affiliated with?**
Moderna is affiliated with the biotechnology and pharmaceutical industries. It is classified under both categories in its Wikidata entry.

**What is the mRNA-1273 vaccine?**
The mRNA-1273 vaccine is an mRNA-based vaccine developed by Moderna for COVID-19. It was the first mRNA vaccine approved for emergency use by the FDA in 2020.

**How many employees does Moderna have?**
Moderna employed 680 employees in 2010 and grew to 5,800 by 2019. The company has experienced significant growth in its workforce over the years.

**What is Moderna's stock ticker symbol?**
Moderna is publicly traded on the Nasdaq stock exchange under the ticker symbol MRNA.

**What is Moderna's revenue history?**
Moderna reported revenues of $60.2 million in 2010, $135.07 million in 2011, and $205.83 million in 2012. Its revenue has fluctuated over the years, reflecting its growth and development in the biotechnology sector.

**What are Moderna's notable achievements?**
Moderna's most notable achievement is the development of the mRNA-1273 vaccine, which was the first mRNA-based COVID-19 vaccine approved for emergency use by the FDA in 2020. This vaccine played a crucial role in the global response to the COVID-19 pandemic.

**Who are the key figures associated with Moderna?**
Key figures associated with Moderna include Noubar Afeyan, Robert S. Langer, and Stéphane Bancel. Afeyan is the founder and former CEO, Langer is a biomedical engineer and co-founder, and Bancel is the current CEO.

## Why It Matters
Moderna matters as a pioneer in biotechnology, particularly in the development of mRNA vaccines. The company's mRNA-1273 vaccine was a game-changer in the fight against COVID-19, becoming the first mRNA-based vaccine approved for emergency use by the FDA in 2020. This vaccine played a crucial role in the global response to the pandemic, providing a highly effective and safe option for vaccination. Moderna's work has had a significant impact on public health, demonstrating the potential of mRNA technology in medicine. The company's innovations have set new standards in vaccine development and have influenced the broader biotechnology industry. Moderna's success has also highlighted the importance of public-private partnerships in addressing global health challenges. By leveraging its expertise in mRNA technology, Moderna continues to contribute to advancements in biotechnology and pharmaceuticals, making it a key player in the field.

## Notable For
- Being the first company to develop and approve an mRNA-based COVID-19 vaccine (mRNA-1273).
- Pioneering mRNA vaccine technology, which has revolutionized vaccine development.
- Having a strong presence in the biotechnology and pharmaceutical industries.
- Being headquartered in Cambridge, Massachusetts, a hub for biotechnology and academic research.
- Employing a significant number of employees, reflecting its growth and expansion.
- Reporting notable revenue and profit figures, indicating its financial success.
- Being publicly traded on the Nasdaq stock exchange, allowing for public investment.
- Having a global Wikipedia presence, indicating its international recognition.
- Being affiliated with key figures in biotechnology and medicine, such as Noubar Afeyan, Robert S. Langer, and Stéphane Bancel.
- Developing innovative products that have had a significant impact on public health.

## Body

### Overview
Moderna is an American biotechnology company specializing in the development and production of mRNA-based vaccines and therapies. Founded in 2010, it is headquartered in Cambridge, Massachusetts, and is publicly traded on the Nasdaq stock exchange. The company is renowned for its breakthrough mRNA-1273 vaccine, which became the first mRNA vaccine approved for COVID-19 in 2020.

### Founding and Leadership
Moderna was founded in 2010 by Noubar Afeyan, Robert S. Langer, and Stéphane Bancel. Afeyan is an American entrepreneur and inventor, Langer is a biomedical engineer, and Bancel is the current CEO. The company was established with the goal of developing innovative biotechnology solutions, particularly in the field of mRNA vaccines.

### Headquarters and Location
Moderna is headquartered in Cambridge, Massachusetts, United States. Cambridge is known for its strong biotechnology and academic institutions, including the Massachusetts Institute of Technology (MIT) and Harvard University. The location has been instrumental in fostering innovation and research in the biotechnology sector.

### Public Trading and Financials
Moderna is publicly traded on the Nasdaq stock exchange under the ticker symbol MRNA. The company has reported revenues of $60.2 million in 2010, $135.07 million in 2011, and $205.83 million in 2012. Its revenue has fluctuated over the years, reflecting its growth and development in the biotechnology sector. Moderna has also reported net profits and losses from 2010 to 2019, with a notable $12.2 billion net profit in 2019.

### Employee Growth
Moderna employed 680 employees in 2010 and grew to 5,800 by 2019. The company has experienced significant growth in its workforce over the years, reflecting its expansion and success in the biotechnology industry.

### Industry Affiliations
Moderna is affiliated with the biotechnology and pharmaceutical industries. It is classified under both categories in its Wikidata entry, indicating its strong presence in these sectors. The company's work has had a significant impact on the development of mRNA vaccines and therapies.

### Notable Achievements
Moderna's most notable achievement is the development of the mRNA-1273 vaccine, which was the first mRNA-based COVID-19 vaccine approved for emergency use by the FDA in 2020. This vaccine played a crucial role in the global response to the COVID-19 pandemic, providing a highly effective and safe option for vaccination. The mRNA-1273 vaccine has been widely distributed and has contributed to the control of the pandemic.

### Key Figures
Key figures associated with Moderna include Noubar Afeyan, Robert S. Langer, and Stéphane Bancel. Afeyan is the founder and former CEO, Langer is a biomedical engineer and co-founder, and Bancel is the current CEO. These individuals have played pivotal roles in the company's development and success.

### Digital Presence and Recognition
Moderna has a Wikipedia presence with 46 sitelinks, indicating its global recognition. The company's website, [modernatx.com](https://www.modernatx.com/), provides information on its products, news, and media. Moderna uses multiple identifiers, including ISIN US60770K1079 and LEI 549300EI6OKH5K5Q2G38, to ensure accurate documentation and retrieval in various databases and encyclopedias.

### Impact on Public Health
Moderna's work has had a significant impact on public health, demonstrating the potential of mRNA technology in medicine. The company's innovations have set new standards in vaccine development and have influenced the broader biotechnology industry. By leveraging its expertise in mRNA technology, Moderna continues to contribute to advancements in biotechnology and pharmaceuticals, making it a key player in the field.

## References

1. [Source](https://www.lobbyfacts.eu/datacard/moderna-inc?rid=011080341579-06)
2. [proxy statement. 2020](https://investors.modernatx.com/static-files/d0f80ad6-4ae5-4fd6-bf87-164f7b4588ba)
3. [proxy statement](https://investors.modernatx.com/node/8461/html)
4. [Fortune.com unicorn list. 2016](https://fortune.com/unicorns/2016/moderna-therapeutics/)
5. Google Knowledge Graph
6. [Source](https://www.macrotrends.net/stocks/charts/MRNA/moderna/number-of-employees)
7. [FDA will consider Moderna's mRNA flu vaccine after all | AP News](https://apnews.com/article/moderna-flu-vaccine-mrna-fda-kennedy-844ddc1d763a3975a0a2af6f67d5895e)
8. BBC Things
9. [Crunchbase](http://www.crunchbase.com/organization/moderna-therapeutics)
10. [annual report](https://investors.modernatx.com/node/8346/html)
11. [Form 10-K. 2022](https://www.sec.gov/Archives/edgar/data/0001682852/000168285222000012/mrna-20211231.htm)
12. [Form 10-K. 2023](https://www.sec.gov/Archives/edgar/data/0001682852/000168285223000011/mrna-20221231.htm)
13. [Form 10-K. 2025](https://www.sec.gov/Archives/edgar/data/1682852/000130817925000081/mrna013406-ars.pdf)
14. [Source](https://finance.yahoo.com/quote/MRNA/)
15. GRID Release 2017-04-04
16. EU Transparency Register
17. Quora
18. Aligned ISNI and Ringgold identifiers for institutions
19. [Source](https://golden.com/wiki/Moderna_Therapeutics-EY4K96)
20. YouTube API
21. [Media kit – Moderna](https://www.modernatx.com/en-US/newsroom/news-and-media/media-kit)